CBx Daily Digest

Who Is Now Lobbying on CBD, and Hemp?

Altria and Anheuser-Busch, previously lobbying on hemp and cannabis respectively, have now specified CBD as an area of interest.

Altria and Anheuser-Busch, previously lobbying on hemp and cannabis respectively, have now specified CBD as an area of interest.

Cannabis lobbying has slowed in 2020, as Cannabis Wire recently reported. But the industry, along with the hemp and CBD industries, continues to draw a diverse mix of stakeholders, both for and against its long-term growth.

Cannabis Wire dug through the latest lobbying disclosures, and found some intriguing new names that have joined these conversations since late 2019. 

Altria (the tobacco giant) has invested in a Canadian cannabis company called Cronos; also, Altria has already been lobbying on hemp, which Cannabis Wire first reported, but this is the first time the company specified CBD.

Anheuser-Bush partnered with Canadian cannabis company Tilray on THC and CBD beverages; also, the company has already been lobbying on “cannabis in food products” since Q2 2019, as Cannabis Wire reported, but now specifies CBD.

Read: Full Reporting and 2020 Lobbying List at CannabisWire (requires free subscription)

To Top